Analysis on the Cross-sectional Data of the Follow-up and Management of 7 235 Patients Members with Chronic Liver Disease

Jinhuan LU,Xuemei LI,Yan GAO,Yanbing LI,Wen MENG,Yan ZHAO,Rongmei LIU
DOI: https://doi.org/10.3969/j.issn.1673-5625.2019.01.027
2019-01-01
Abstract:Objective To analyze the cross-sectional data of follow-up and management (including data about basic characteristics, diseases, anti-virus medications and outcomes) for patients members with chronic liver disease from You'an hospital since 2012, and to provide reference for the management of follow-up.Methods SPSS 20.0 statistical software was used and descriptive analysis method was applied to analyze the data.Results Among 7 235 patients, 52.0% were non-permanent residents.71.2% of the patients were infected with both HBV and HCV.61.9% were HBV infected patients.Entecavir was used for a longer time than other antiviral drugs.Drugs was used more than 1 year among 83.2% of the patients.The successful rate of telephone follow-up was about 50%.78% of the members could complete the telephone follow-up after answering the phone.Conclusion In this investigation, the rate of lost to follow-up was high.Patients with non-infectious chronic liver disease or who received treatment for prevention of mother-to-child transmission were uncompliant.Generally members lacked awareness and ability of self-health-management.Multiple measures should be applied to improve the regular referral and health awareness of patients to reduce the rate of lost to follow-up.Non-infectious chronic liver disease members should be paid more attention.And the standardization and individualization of the follow-up management should be combined to improve accuracy of the antiviral drugs treatment.
What problem does this paper attempt to address?